Industry Insights
-
Turn AI Visibility Into Action: Build Explanation Layers For Different Stakeholders
9/4/2026
AI visibility isn’t just about being found. Ross Jackson coaches sponsors on how to influence AI to provide clear stakeholder pathways for clinical trial involvement.
-
5 Ways To Enrich The Clinical Trial Ecosystem
9/4/2026
Sponsors must treat sites, PIs, and patients as connected parts of a living clinical trial ecosystem. Here are five ways to help make that happen.
-
Participant Support Exists. Are Sites Able To Use It?
9/3/2026
Participant support can exist without being consistently used. Explore why site adoption, workflow fit, and continued access deserve attention throughout the life of a clinical study.
-
Who Owns The Work Behind Clinical Trial Complexity?
9/3/2026
Site burden often points to unclear ownership. This article examines how recurring administrative work reaches sites, where standardization helps, and when responsibility should shift.
-
Your Trial Shows Up In AI. Now What?
9/3/2026
AI can explain your trial — but can it help patients act? Ross Jackson shares how sponsors can turn visibility into trust and next steps.
-
The Promise Of MRD-Guided CAR-T Treatment
9/3/2026
Minimal residual disease markers can reveal relapse before clinical signs appear, when off-the-shelf cell therapy may have its greatest advantage.
-
Dose Escalation, Combination Strategy Keep Aprea Ahead In Its Oncology Trials
9/2/2026
Aprea’s Gene Kennedy explains how smart dose escalation, next-gen sequencing, and combination planning are helping the company advance its oncology trial for multiple solid tumor types.
-
How A $96M Gift Is Transforming Pediatric Brain Cancer Clinical Trial Infrastructure
9/1/2026
By pairing donor priorities with research needs at Children's National, Milken Institute SPARC is turning philanthropy into faster trials, stronger infrastructure, and long-term care goals.
-
Lessons In Forecasting Discipline From A $40B Supply Chain
8/31/2026
Forecasting errors rarely start with the algorithm. They start when protocol changes, enrollment and site data reach the supply plan too late to prevent waste and disruption.
-
Tech-Enabled FSP Delivery
8/29/2026
Struggling with data silos and delayed trial visibility? See how combining AI with smarter data integration helps teams gain real-time visibility without adding headcount.